Total Payments
$2,322
2024 Payments
$73.86
Companies
15
Transactions
41
Medicare Patients
11,723
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$1,344 (57.9%)
Travel$948.11 (40.8%)
Education$30.54 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,344 | 37 | 57.9% |
| Travel and Lodging | $948.11 | 2 | 40.8% |
| Education | $30.54 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bovie Medical Corporation | $1,008 | 6 | $0 (2017) |
| Galderma Laboratories, L.P. | $669.46 | 12 | $0 (2022) |
| PFIZER INC. | $130.94 | 4 | $0 (2023) |
| AbbVie Inc. | $93.89 | 2 | $0 (2021) |
| Janssen Biotech, Inc. | $79.68 | 3 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $53.88 | 1 | $0 (2017) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $47.33 | 1 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $41.15 | 2 | $0 (2023) |
| GENZYME CORPORATION | $37.37 | 1 | $0 (2024) |
| REVANCE THERAPEUTICS, INC. | $36.49 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $73.86 | 3 | GENZYME CORPORATION ($37.37) |
| 2023 | $143.55 | 7 | PFIZER INC. ($62.81) |
| 2022 | $89.81 | 1 | Galderma Laboratories, L.P. ($89.81) |
| 2021 | $27.67 | 2 | AbbVie Inc. ($14.37) |
| 2020 | $32.84 | 2 | Regeneron Healthcare Solutions, Inc. ($17.40) |
| 2019 | $58.34 | 2 | Janssen Biotech, Inc. ($58.34) |
| 2018 | $95.00 | 3 | PFIZER INC. ($68.13) |
| 2017 | $1,801 | 21 | Bovie Medical Corporation ($1,008) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.37 | General |
| Category: Immunology | ||||||
| 10/02/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 03/05/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 09/22/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.35 | General |
| Category: Immunology | ||||||
| 06/20/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: Dermatology | ||||||
| 05/24/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.35 | General |
| Category: Immunology | ||||||
| 04/11/2023 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 03/30/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/24/2023 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 02/15/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $32.27 | General |
| Category: DERMATOLOGY | ||||||
| 08/20/2022 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $89.81 | General |
| 05/24/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: IMMUNOLOGY | ||||||
| 02/13/2021 | Allergan, Inc. | KYBELLA (Biological) | Food and Beverage | In-kind items and services | $13.30 | General |
| 11/05/2020 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.44 | General |
| 07/02/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/18/2019 | Janssen Biotech, Inc. | Tremfya (Drug), STELARA | Food and Beverage | In-kind items and services | $31.69 | General |
| Category: Immunology | ||||||
| 02/20/2019 | Janssen Biotech, Inc. | Tremfya (Drug), STELARA | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Immunology | ||||||
| 12/10/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $68.13 | General |
| Category: DERMATOLOGY | ||||||
| 09/28/2018 | Allergan Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $13.43 | General |
| 08/15/2018 | DUSA Pharmaceuticals, Inc. | Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution, 20% (Drug), BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Dermatology | ||||||
| 12/02/2017 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $79.70 | General |
| 12/02/2017 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $79.70 | General |
| 10/20/2017 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $9.22 | General |
| 10/12/2017 | Valeant Pharmaceuticals North America LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $53.88 | General |
| Category: DERMATOLOGY | ||||||
| 10/12/2017 | NOVARTIS PHARMACEUTICALS CORPORATION | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $47.33 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,808 | 7,324 | $965,129 | $360,806 |
| 2022 | 25 | 3,154 | 7,956 | $1.0M | $416,485 |
| 2021 | 24 | 3,149 | 7,818 | $894,910 | $381,712 |
| 2020 | 23 | 2,612 | 6,912 | $734,296 | $315,276 |
Total Patients
11,723
Total Services
30,010
Medicare Billing
$1.5M
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 499 | 1,021 | $132,730 | $65,484 | 49.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 286 | 422 | $177,240 | $57,048 | 32.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 339 | 466 | $79,220 | $37,116 | 46.9% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 47 | 59 | $70,977 | $32,689 | 46.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 373 | 1,028 | $154,200 | $30,497 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 214 | 288 | $54,720 | $26,718 | 48.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 179 | 376 | $36,472 | $15,745 | 43.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 205 | 2,438 | $63,388 | $13,379 | 21.1% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 16 | 34 | $25,466 | $11,696 | 45.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 215 | 259 | $36,260 | $10,726 | 29.6% |
| 11606 | Removal of cancer skin growth of body, arms, or legs, more than 4.0 cm | Office | 2023 | 22 | 29 | $22,417 | $10,088 | 45.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 122 | 122 | $23,180 | $9,255 | 39.9% |
| 15576 | Creation of flap graft to eyelids, nose, ears, lips, or mouth | Office | 2023 | 12 | 13 | $14,365 | $8,332 | 58.0% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 15 | 27 | $12,960 | $8,280 | 63.9% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 15 | 25 | $8,750 | $5,989 | 68.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 49 | 55 | $11,550 | $5,433 | 47.0% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 20 | 22 | $11,044 | $4,859 | 44.0% |
| 11604 | Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm | Office | 2023 | 17 | 21 | $15,477 | $4,859 | 31.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 74 | 123 | $5,043 | $1,267 | 25.1% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 16 | 19 | $2,470 | $975.26 | 39.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 73 | 477 | $7,200 | $368.57 | 5.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 571 | 1,207 | $148,507 | $80,255 | 54.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 298 | 437 | $179,820 | $60,944 | 33.9% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 62 | 73 | $82,199 | $40,983 | 49.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 363 | 499 | $80,022 | $40,098 | 50.1% |
About Dr. Gerald Bock, MD
Dr. Gerald Bock, MD is a Dermatology healthcare provider based in Stockton, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376649269.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerald Bock, MD has received a total of $2,322 in payments from pharmaceutical and medical device companies, with $73.86 received in 2024. These payments were reported across 41 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,344).
As a Medicare-enrolled provider, Bock has provided services to 11,723 Medicare beneficiaries, totaling 30,010 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Stockton, CA
- Active Since 09/16/2006
- Last Updated 07/08/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1376649269
Products in Payments
- EUCRISA (Drug) $100.40
- Humira (Biological) $79.52
- DUPIXENT (Biological) $78.52
- Tremfya (Drug) $58.34
- SILIQ (Drug) $53.88
- COSENTYX (Biological) $47.33
- DAXXIFY (Drug) $36.49
- Sotyktu (Drug) $30.70
- CIBINQO (Drug) $30.54
- STELARA (Biological) $26.43
- Xeomin (Biological) $26.29
- GUSELKUMAB (Biological) $21.34
- HUMIRA (Biological) $14.37
- Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution, 20% (Drug) $13.44
- BOTOX COSMETIC (Biological) $13.43
- KYBELLA (Biological) $13.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Stockton
Stuart Jacobs, Md, MD
Dermatology — Payments: $14,711
Dermatology $14,711
Walter Yourchek, Md, MD
Dermatology — Payments: $1,819
Dermatology $1,819
Kyle Herbold, M.d, M.D
Dermatology — Payments: $1,745
Dermatology $1,745
Dr. Christy Behnam, Md, MD
Dermatology — Payments: $1,443
Dermatology $1,443
Lydia Kim, M.d, M.D
Dermatology — Payments: $1,404
Dermatology $1,404
Karen Bissell, Md, MD
Dermatology — Payments: $766.31
Dermatology $766.31